Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Cangene Corporation
LifeSignals received 510(k) clearance for its Wireless Medical Biosensor LP1250, which can be integrated into third-party devices to remotely monitor patients for common cardiac arrythmias.
Sergey Young is on a mission to "extend healthy lifespans" by investing in longevity breakthroughs. Last year, the venture capitalist established a $100m fund investing in technologies with the potential to improve healthy long living.
US FDA’s Medical Countermeasures Initiative authorities like emergency use authorization have not yet had much of an impact on drugs and biologics, but agency is committed to supporting a swift response to the new strain of coronavirus.
German Industry Says MDR Implementation 'Too Slow' But Negative Economic Effects Still Largely Unreported
The European Commission needs to be faster and more efficient in its implementation of the new EU Medical Device Regulation (MDR), say German manufacturers, watching the remaining months of transition time slip into single figures. A few economic operators have come clean about the pressure the MDR has brought to bear, but the suspicion is that many are choosing to keep quiet.
- Contract Research, Toxicology Testing-CRO
- Specialty Pharmaceuticals
- Other Names / Subsidiaries
- Chesapeake Biological Laboratories, Inc.
- Twinstrand Therapeutics Inc.